Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
14.25
-0.19 (-1.32%)
Apr 8, 2026, 3:04 PM CST

SHE:002675 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
11,75011,33010,07715,11513,65512,659
Market Cap Growth
8.78%12.44%-33.33%10.69%7.87%-20.74%
Enterprise Value
12,54312,15310,93415,76613,99213,487
Last Close Price
14.2513.7412.1918.0416.1315.18
PE Ratio
60.0857.9254.8272.0744.4483.52
Forward PE
35.6335.9232.6235.7930.3928.05
PS Ratio
4.294.133.514.613.813.24
PB Ratio
2.152.071.882.802.592.52
P/TBV Ratio
7.457.185.837.516.236.91
P/FCF Ratio
53.6551.73--22.5030.62
P/OCF Ratio
20.2619.5435.0954.5813.7013.42
EV/Sales Ratio
4.584.433.814.813.913.45
EV/EBITDA Ratio
22.8622.9025.0230.8120.8218.53
EV/EBIT Ratio
35.6234.5138.6942.1825.3622.00
EV/FCF Ratio
57.2755.49--23.0532.62
Debt / Equity Ratio
0.140.140.170.150.130.21
Debt / EBITDA Ratio
1.411.412.011.521.011.44
Debt / FCF Ratio
3.543.54--1.132.54
Net Debt / Equity Ratio
-0.06-0.060.000.02-0.070.02
Net Debt / EBITDA Ratio
-0.60-0.60-0.010.25-0.540.13
Net Debt / FCF Ratio
-1.46-1.460.03-0.54-0.600.23
Asset Turnover
0.310.310.340.400.450.52
Inventory Turnover
2.302.301.961.942.022.41
Quick Ratio
1.281.281.050.750.830.91
Current Ratio
1.641.641.461.271.331.42
Return on Equity (ROE)
2.85%2.85%2.63%4.76%6.85%5.22%
Return on Assets (ROA)
2.46%2.46%2.11%2.87%4.36%5.09%
Return on Invested Capital (ROIC)
4.98%4.90%3.35%5.40%8.71%8.84%
Return on Capital Employed (ROCE)
4.60%4.60%4.10%6.10%9.50%10.90%
Earnings Yield
1.66%1.73%1.82%1.39%2.25%1.20%
FCF Yield
1.86%1.93%-1.68%-1.55%4.45%3.27%
Dividend Yield
0.55%0.58%0.66%0.69%0.93%0.99%
Payout Ratio
12.65%56.42%118.18%123.17%81.76%199.57%
Buyback Yield / Dilution
-0.01%-0.01%0.01%-2.10%-0.68%-0.01%
Total Shareholder Return
0.54%0.58%0.66%-1.41%0.25%0.97%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.